Drugs in Development
About 14 results
At the forefront of the molecular biology revolution, more than 500,000 customers worldwide are using QIAGEN Sample & Assay Technologies to achieve breakthroughs based on the building blocks of life – DNA, RNA and proteins. Doctors are diagnosing diseases more precisely and quickly to guide treatment decisions. Scientists are con...
Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Qiagen
This week, Phispers looks at the drastic steps taken by Teva's Kare Schultz as he pulls out the axe in his first month as CEO of the Israeli drug maker. In the UK, Merck and Qiagen pledge investments and give a thumbs up to the country's new industrial strategy. Meanwhile, the US FDA added a data update to its Orange Book to bring transpa...
NVHRBQOZEMFKLD-CUYJMHBOSA-N DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News
Missing: qiagen
NVKQPOHDVWNXRP-UHFFFAOYSA-N DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News
Missing: qiagen
NVMNEWNGLGACBB-UHFFFAOYSA-N DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News
Missing: qiagen
NVPOUMXZERMIJK-OLZOCXBDSA-N DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News
Missing: qiagen
NVSLOKHCHIFJDR-UHFFFAOYSA-N DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News
Missing: qiagen
NVZFZMCNALTPBY-XVFCMESISA-N DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News
Missing: qiagen
Abliva AB is a leader in mitochondrial medicine, with one project in clinical phase I (KL1333) for chronic treatment of primary mitochondrial diseases and one project, in preparation for clinical trials (NV354), for treatment of primary mitochondrial diseases with Complex I deficiency. NeuroSTAT for traumatic brain injury (TBI) is ready t...
Missing: qiagen
Complete the form on this page and let us know what you're looking for (API, Finished Drug Products, Excipients, Contract Services (CMO, CRO, CDMO etc.).
The more detailed your request, the quicker we can shortlist companies which will meet your requirements.
Our team will reach out to you over email or phone to better understand your needs.
We select the partner companies matching your requirements from our database (more than 5,000 companies) & also call the right contact within the supplier organization.
Once the companies have confirmed that they can meet your needs and are interested in the opportunity, we connect you directly with the right contact by email.
There are no commissions or other conditions attached.
Market Place
Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace
